BiologicalDrug
Candida albicans clinical trials
Also written Candida antigen.
- studies test it
- 6
- open now
- 1
- in phase 3
- 2
- first study started
- 2007
Keep track of what changes. Save the Candida albicans studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
Assiut University (2) · Benha University (1) · Zagazig University (1) · University of Arkansas (1) · Sohag University (1)
Often tested with
Tested in the same studies.
Salicylic Acid (1) · Lactic Acid (1) · Measles-Mumps-Rubella Vaccine (1) · Podophyllin (1)
Studies
Open first, then newest update. How each study uses Candida albicans is read from its arms, and is right about nine times in ten.
Testing it · 6
- Sclerotherapy and Candida Antigen in Treatment of Common WartsNot yet recruitingNot applicableSohag UniversityNCT06749665Written as candida antigen
- Combination Therapy for Warts: Candida Antigen vs. Topical KeratolyticCompletedPhase 2Benha UniversityNCT07329907Written as Candida Antigen and Salicylic Acid/Lactic Acid
- Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous WartsCompletedPhase 2Zagazig UniversityNCT04399577Written as Candida antigen
- Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital WartsStatus unknownPhase 3Assiut UniversityNCT03853785Written as Candida antigen
- Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous WartsStatus unknownPhase 3Assiut UniversityNCT03158168Written as Candida Antigen
- Study With Candida Antigen for Treatment of WartsCompletedPhase 1University of ArkansasNCT00569231Written as Candida Antigen
Codes
What other systems call Candida albicans · ClinicalTrials.gg INT014850
- UNII (FDA) 4D7G21HDBCCANDIDA ALBICANSConfirmed FDA, Wikidata
- RxNorm 1963One source FDA
- Wikidata Q310443Candida albicansConfirmed FDA, Wikidata
- NCI Thesaurus C77170Candida albicansOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4D7G21HDBC | CANDIDA ALBICANS | Confirmed FDA, Wikidata |
| RxNorm | 1963 | — | One source FDA |
| Wikidata | Q310443 | Candida albicans | Confirmed FDA, Wikidata |
| NCI Thesaurus | C77170 | Candida albicans | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.